Skip to content

BMY vs WST: Dividend Comparison

BMY$60.77
Bristol Myers Squibb Co
Health Care
vs
WST$415.45
West Pharmaceutical Services Inc
Health Care

Dividend data as of

Bristol Myers Squibb Co (BMY) and West Pharmaceutical Services Inc (WST) are both in the Health Care sector, making them natural rivals for dividend investors. BMY offers a significantly higher 4.00% yield compared to WST's 0.25%, a gap of 3.75%. Both stocks show similar dividend growth rates, each around 5.1% over the past five years. Both stocks carry a "Safe" dividend safety rating. BMY is a Dividend Contender while WST is a Dividend Aristocrat.

Verdict

Best for Income
BMY
Higher yield at 4.00%
Best for Growth
WST
5yr CAGR of 5.9%
Best for Safety
WST
Lower payout ratio (10%)

Track BMY and WST in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$60.77
$415.45
Dividend Yield
4.00%
0.25%
Annual Dividend
$2.52
$1.04
5yr Div CAGR
5.1%
5.9%
3yr Div CAGR
3.4%
6.1%
Consecutive Years
18
33
Payout Ratio
55.88%
9.88%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$400/yr
$25/yr

Yield Analysis

BMY
4.00%
WST
0.25%

BMY yields 3.75% more than WST. In dollar terms, BMY pays $2.52/share vs WST's $1.04/share annually.

Dividend Growth

BMY 5yr CAGR
5.1%
decelerating
WST 5yr CAGR
5.9%
steady

BMY: Dividend growth is slowing — the 3-year CAGR of 3.4% trails the 5-year rate of 5.1% and the 10-year rate of 5.2%.

WST: Dividend growth has been steady, with a 3-year CAGR of 6.1% and a 5-year CAGR of 5.9% (10-year: 6.5%).

Dividend Safety

BMY
Safe
Payout Ratio56%
WST
Safe
Payout Ratio10%

BMY: The payout ratio of 56% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 1.8x.

WST: The payout ratio of 10% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 8.6x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BMY
WST
$10,000
$400/yr
$25/yr
$50,000
$2,002/yr
$125/yr
$100,000
$4,004/yr
$251/yr

What does $10,000 buy in BMY vs WST today?

At $60.77 per share, $10,000 buys about 164.6 shares of Bristol Myers Squibb Co (BMY). Each share pays $2.52 per year in dividends, so the position starts out generating roughly $415 per year — about $35 a month.

At $415.45 per share, $10,000 buys about 24.1 shares of West Pharmaceutical Services Inc (WST). Each share pays $1.04 per year in dividends, so the position starts out generating roughly $25 per year — about $2 a month.

BMY is the larger income stream from day one: $390 per year more on the same $10,000 invested.

What could $10,000 of BMY or WST income look like in 10 years?

Bristol Myers Squibb Co (BMY) has raised its dividend about 5.1% a year over the past five years. If that pace held, the $400 per year that $10,000 generates today at the current 4.00% yield would reach $662 per year by 2036 — a 6.6% yield on the original cost.

West Pharmaceutical Services Inc (WST) has raised its dividend about 5.9% a year over the past five years. If that pace held, the $25 per year that $10,000 generates today at the current 0.25% yield would reach $45 per year by 2036 — a 0.4% yield on the original cost.

On those trailing rates, BMY pays more in 2036: $662 versus $45 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would WST's dividend growth overtake BMY's higher yield?

Not within a realistic holding period. West Pharmaceutical Services Inc (WST) is growing its dividend faster (5.9% vs 5.1% a year), but the starting-yield gap — 4.00% for BMY vs 0.25% for WST — is wide enough that the crossover sits more than 30 years out on trailing rates. For income you plan to spend, BMY's head start is decisive.

Can BMY and WST afford their dividends?

Bristol Myers Squibb Co (BMY) earns $4.51 per share against $2.52 paid out in dividends — 1.8x coverage (a 56% payout ratio).

West Pharmaceutical Services Inc (WST) earns $8.91 per share against $1.04 paid out in dividends — 8.6x coverage (a 10% payout ratio).

WST's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for BMY if earnings weaken.

Which fits an early-retirement income portfolio better, BMY or WST?

For income you need right now, Bristol Myers Squibb Co (BMY) leads: $100,000 invested today pays about $334 a month at the current 4.00% yield, versus $21 a month from West Pharmaceutical Services Inc (WST) at 0.25%.

With a decade or more before the income is needed, WST's faster dividend growth (5.9% vs 5.1% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: BMY has raised its dividend 18 consecutive years; WST has raised its dividend 33 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $980/yr in BMY vs $46/yr in WST by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.